...
search icon
qnrx-img

Quoin Pharmaceuticals Ltd DRC Share Price

QNRX
NAQ
$8.4
+$0.13
(1.57%)
1D
Industry: Biotechnology Sector: Health Care

Quoin Pharmaceuticals Ltd DRC Analyst Forecast

Quoin Pharmaceuticals Ltd DRC Share Price Chart

Quoin Pharmaceuticals Ltd DRC Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$13.37M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
3.68K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.87
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$5.01 L
$23.5 H
$8.4

About Quoin Pharmaceuticals Ltd DRC, Common Stock

Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc. more

Industry: BiotechnologySector: Health Care

Quoin Pharmaceuticals Ltd DRC Stock Returns

Time FrameQNRXSectorS&P500
1-Week Return17.65%-1.08%-1.38%
1-Month Return-23.01%-0.47%-1.81%
3-Month Return-37.41%2.13%1.38%
6-Month Return16.99%17.04%5.68%
1-Year Return-27.49%6.56%11.74%
3-Year Return-98.73%16.78%65.15%
5-Year Return-99.99%34.34%73.68%
10-Year Return-100%137.88%260.03%

Quoin Pharmaceuticals Ltd DRC Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue104.77K104.11K103.64K103.44K100.47K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.37,"profit":true},{"date":"2022-12-31","value":98.91,"profit":true},{"date":"2023-12-31","value":98.73,"profit":true},{"date":"2024-12-31","value":95.9,"profit":true}]
Gross Profit(104.77K)(104.11K)(103.64K)(103.44K)(100.47K)[{"date":"2020-12-31","value":-10477300,"profit":false},{"date":"2021-12-31","value":-10411500,"profit":false},{"date":"2022-12-31","value":-10363500,"profit":false},{"date":"2023-12-31","value":-10343800,"profit":false},{"date":"2024-12-31","value":-10047400,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses1.67M6.06M9.26M9.38M9.53M[{"date":"2020-12-31","value":17.53,"profit":true},{"date":"2021-12-31","value":63.63,"profit":true},{"date":"2022-12-31","value":97.16,"profit":true},{"date":"2023-12-31","value":98.43,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(1.67M)(6.06M)(9.26M)(9.38M)(9.53M)[{"date":"2020-12-31","value":-167001000,"profit":false},{"date":"2021-12-31","value":-606285000,"profit":false},{"date":"2022-12-31","value":-925770400,"profit":false},{"date":"2023-12-31","value":-937850400,"profit":false},{"date":"2024-12-31","value":-952846500,"profit":false}]
Total Non-Operating Income/Expense(472.38K)(16.77M)(742.13K)1.31M1.12M[{"date":"2020-12-31","value":-36.1,"profit":false},{"date":"2021-12-31","value":-1281.14,"profit":false},{"date":"2022-12-31","value":-56.71,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":85.93,"profit":true}]
Pre-Tax Income(2.10M)(21.46M)(9.38M)(8.69M)(8.96M)[{"date":"2020-12-31","value":-209536400,"profit":false},{"date":"2021-12-31","value":-2146258800,"profit":false},{"date":"2022-12-31","value":-938149600,"profit":false},{"date":"2023-12-31","value":-868657300,"profit":false},{"date":"2024-12-31","value":-896247200,"profit":false}]
Income Taxes(331.31K)(12.94M)(104.04K)22.38K(8.95B)[{"date":"2020-12-31","value":-1480.13,"profit":false},{"date":"2021-12-31","value":-57826.66,"profit":false},{"date":"2022-12-31","value":-464.81,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-39999405.79,"profit":false}]
Income After Taxes(1.76M)(8.52M)(9.28M)(8.71M)8.94B[{"date":"2020-12-31","value":-0.02,"profit":false},{"date":"2021-12-31","value":-0.1,"profit":false},{"date":"2022-12-31","value":-0.1,"profit":false},{"date":"2023-12-31","value":-0.1,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Continuous Operations(2.10M)(21.46M)(9.38M)(8.64M)(8.96M)[{"date":"2020-12-31","value":-209536400,"profit":false},{"date":"2021-12-31","value":-2146258800,"profit":false},{"date":"2022-12-31","value":-938149600,"profit":false},{"date":"2023-12-31","value":-863765500,"profit":false},{"date":"2024-12-31","value":-896247200,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(2.10M)(21.46M)(9.38M)(8.69M)(8.96M)[{"date":"2020-12-31","value":-209536400,"profit":false},{"date":"2021-12-31","value":-2146258800,"profit":false},{"date":"2022-12-31","value":-938149600,"profit":false},{"date":"2023-12-31","value":-868657300,"profit":false},{"date":"2024-12-31","value":-896247200,"profit":false}]
EPS (Diluted)(0.10)(315.89)(7.09)(6.50)(2.25)[{"date":"2020-12-31","value":-10,"profit":false},{"date":"2021-12-31","value":-31588.59,"profit":false},{"date":"2022-12-31","value":-709,"profit":false},{"date":"2023-12-31","value":-650,"profit":false},{"date":"2024-12-31","value":-224.81,"profit":false}]

Quoin Pharmaceuticals Ltd DRC Ratios

Quoin Pharmaceuticals Ltd DRC Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

QNRX
Cash Ratio 0.94
Current Ratio 1.04

Quoin Pharmaceuticals Ltd DRC Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

QNRX
ROA (LTM) -99.47%
ROE (LTM) -651.40%

Quoin Pharmaceuticals Ltd DRC Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

QNRX
Debt Ratio Lower is generally better. Negative is bad. 1.19
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.19

Quoin Pharmaceuticals Ltd DRC Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

QNRX
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.68
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Quoin Pharmaceuticals Ltd DRC share price today?

Quoin Pharmaceuticals Ltd DRC (QNRX) share price today is $8.4

Can Indians buy Quoin Pharmaceuticals Ltd DRC shares?

Yes, Indians can buy shares of Quoin Pharmaceuticals Ltd DRC (QNRX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in QNRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Quoin Pharmaceuticals Ltd DRC be purchased?

Yes, you can purchase fractional shares of Quoin Pharmaceuticals Ltd DRC (QNRX) via the Vested app. You can start investing in Quoin Pharmaceuticals Ltd DRC (QNRX) with a minimum investment of $1.

How to invest in Quoin Pharmaceuticals Ltd DRC shares from India?

You can invest in shares of Quoin Pharmaceuticals Ltd DRC (QNRX) via Vested in three simple steps:

  • Click on Sign Up or Invest in QNRX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Quoin Pharmaceuticals Ltd DRC shares
What is Quoin Pharmaceuticals Ltd DRC 52-week high and low stock price?

The 52-week high price of Quoin Pharmaceuticals Ltd DRC (QNRX) is $23.5. The 52-week low price of Quoin Pharmaceuticals Ltd DRC (QNRX) is $5.01.

What is Quoin Pharmaceuticals Ltd DRC price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Quoin Pharmaceuticals Ltd DRC (QNRX) is

What is Quoin Pharmaceuticals Ltd DRC price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Quoin Pharmaceuticals Ltd DRC (QNRX) is 1.68

What is Quoin Pharmaceuticals Ltd DRC dividend yield?

The dividend yield of Quoin Pharmaceuticals Ltd DRC (QNRX) is 0.00%

What is the Market Cap of Quoin Pharmaceuticals Ltd DRC?

The market capitalization of Quoin Pharmaceuticals Ltd DRC (QNRX) is $13.37M

What is Quoin Pharmaceuticals Ltd DRC's stock symbol?

The stock symbol (or ticker) of Quoin Pharmaceuticals Ltd DRC is QNRX

How Can Investors Use Quoin Pharmaceuticals Ltd DRC Share Price Data for Long-Term Investment Decisions?

Consider the share price of Quoin Pharmaceuticals Ltd DRC as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Quoin Pharmaceuticals Ltd DRC has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Quoin Pharmaceuticals Ltd DRC shares for Indian investors?

When investing in Quoin Pharmaceuticals Ltd DRC shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Quoin Pharmaceuticals Ltd DRC stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Quoin Pharmaceuticals Ltd DRC share price with other stocks in the same sector?

Rather than merely checking the share price of Quoin Pharmaceuticals Ltd DRC and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Quoin Pharmaceuticals Ltd DRC stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top